Your cart is empty.
Tecan, a global leader in laboratory automation and detection, has been granted DLReady™ certification status for its high-end multimode readers Infinite® M1000 and Infinite F500, by Promega Corporation, USA, a provider of innovative solutions and technical support to the life sciences industry.
The multimode microplate readers have met Promega’s acceptance criteria for being certified as DLReady™ in the corresponding validation program managed by Promega. The certification demonstrates compatibility with the Dual-Luciferase Assay and underlines the excellent injector and flash luminescence performance of Tecan’s Infinite M1000 and Infinite F500 multimode microplate readers.
The Infinite M1000 is Tecan’s new, high-end, premium Quad4 Monochromators™-based multimode instrument, providing outstanding flexibility, sensitivity and speed for demanding applications in drug discovery, life sciences and research. Its new luminescence technology and injector option makes it the obvious successor to Tecan’s high performance Safire2™ microplate reader.
The Infinite F500, Tecan’s high-end, filter-based multimode instrument, is Tecan’s most sensitive filter-based detection platform yet. It is based on the latest technological developments to provide a multifunctional and modular system that rapidly analyzes all your luminescence and fluorescence-based assays at outstanding sensitivity levels. The optional integration of reagent injectors (two injectors with selectable volumes), make this a powerful and versatile drug discovery tool in assay development and screening.
DLReady is a trademark of Promega Corporation, Madison, WI, USA.
Tecan (www.tecan.com) is a leading global supplier of laboratory instruments and solutions for the biopharma, forensic and diagnostic industries. The company specializes in the development, production and distribution of automation solutions for life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of automated laboratory storage and logistics systems. Tecan's clients include pharmaceutical and biotech companies, university research departments, diagnostic laboratories and companies as well as forensics laboratories. Founded in Switzerland in 1980, the company has production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2007, Tecan achieved sales of CHF 414.4 million (USD 345.3 million; EUR 252.7 million). Registered shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).
Tecan Group Ltd.
T +41 44 922 81 11
F +41 44 922 81 12